Judy E. Garber

1988–2026 年に発表

別表記
Judy E Garber
252
論文数
63,169
被引用数
130
h 指数
247
i10 指数

被引用数

Judy E. Garber の年別被引用数1945 年: 被引用 2 件1971 年: 被引用 1 件1982 年: 被引用 1 件1985 年: 被引用 2 件1987 年: 被引用 1 件1989 年: 被引用 1 件1991 年: 被引用 3 件1992 年: 被引用 6 件1993 年: 被引用 24 件1994 年: 被引用 72 件1995 年: 被引用 106 件1996 年: 被引用 128 件1997 年: 被引用 195 件1998 年: 被引用 129 件1999 年: 被引用 125 件2000 年: 被引用 182 件2001 年: 被引用 205 件2002 年: 被引用 263 件2003 年: 被引用 191 件2004 年: 被引用 236 件2005 年: 被引用 247 件2006 年: 被引用 249 件2007 年: 被引用 269 件2008 年: 被引用 301 件2009 年: 被引用 322 件2010 年: 被引用 485 件2011 年: 被引用 428 件2012 年: 被引用 408 件2013 年: 被引用 447 件2014 年: 被引用 524 件2015 年: 被引用 520 件2016 年: 被引用 612 件2017 年: 被引用 681 件2018 年: 被引用 630 件2019 年: 被引用 1,904 件2020 年: 被引用 1,956 件2021 年: 被引用 1,946 件2022 年: 被引用 1,538 件2023 年: 被引用 1,120 件2024 年: 被引用 1,807 件2025 年: 被引用 752 件2026 年: 被引用 23 件1946〜1970 年は被引用が無いため表示していません1972〜1981 年は被引用が無いため表示していません1983〜1984 年は被引用が無いため表示していません1986 年は被引用が無いため表示していません1988 年は被引用が無いため表示していません1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,161 件、この内訳の 28.1%イギリス: 引用元論文 1,994 件、この内訳の 7.8%中国: 引用元論文 1,614 件、この内訳の 6.3%カナダ: 引用元論文 1,216 件、この内訳の 4.8%イタリア: 引用元論文 1,166 件、この内訳の 4.6%ドイツ: 引用元論文 1,062 件、この内訳の 4.2%フランス: 引用元論文 902 件、この内訳の 3.5%オーストラリア: 引用元論文 879 件、この内訳の 3.5%オランダ: 引用元論文 828 件、この内訳の 3.2%スペイン: 引用元論文 725 件、この内訳の 2.8%日本: 引用元論文 530 件、この内訳の 2.1%スウェーデン: 引用元論文 485 件、この内訳の 1.9%
0%28.1%その他 27.2%

分野

  • Medicine47.5%
  • Biochemistry, Genetics and Molecular Biology46.2%
  • Immunology and Microbiology1.7%
  • Computer Science1%
  • Psychology0.8%
  • Engineering0.5%
  • その他2.3%

トピック

  • BRCA gene mutations in cancer7.8%
  • Cancer Genomics and Diagnostics6%
  • Genetic factors in colorectal cancer4.6%
  • DNA Repair Mechanisms4.4%
  • PARP inhibition in cancer therapy4.3%
  • Breast Cancer Treatment Studies4.1%
  • その他68.8%

共著者

全論文

検索で開く
  1. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer - New England Journal of Medicine 2021 被引用: 1,665

  2. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 被引用: 803

  3. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke ほか 509 名 - Annals of Oncology 2022 被引用: 447

  4. Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2016 被引用: 1,163

  5. Mutational Processes Molding the Genomes of 21 Breast Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip J. Stephens, Stuart McLaren, Adam P. Butler, Jon W. Teague, Göran Jönsson, Judy E. Garber, Daniel P. Silver, Penelope Miron, Aquila Fatima, Sandrine Boyault, Anita Langerød, Andrew Tutt, John W.M. Martens, Samuel Aparício, Åke Borg, Anne Vincent Salomon, Gilles Thomas, Anne‐Lise Børresen‐Dale, Andrea L. Richardson, Michael S. Neuberger, P. Andrew Futreal, Peter J. Campbell, Michael R. Stratton - Cell 2012 被引用: 2,023

  6. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carl Blomqvist, Natalia Bogdanova, Stig E. Bojesen, Bernardo Bonanni, Davide Bondavalli, Åke Borg, Hiltrud Brauch, Hermann Brenner, Ignacio Briceño, Annegien Broeks, Sara Y. Brucker, Thomas Brüning, Barbara Burwinkel, Saundra S. Buys, Helen Byers, Trinidad Caldés, Maria A. Caligo, Mariarosaria Calvello, Daniele Campa, Jose E. Castelao, Jenny Chang‐Claude, Stephen J. Chanock, Melissa Christiaens, Hans Christiansen, Wendy K. Chung, Kathleen Claes, Christine L. Clarke, Sten Cornelissen, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Mary B. Daly, Peter Devilee, Orland Dı́ez, Susan M. Domchek, Thilo Dörk, Miriam Dwek, Diana M. Eccles, Arif B. Ekici, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Lenka Foretová, Florentia Fostira, Eitan Friedman, Debra Frost, Manuela Gago-Domínguez, Susan M. Gapstur, Judy E. Garber, José Á. García-Sáenz, Mia M. Gaudet, Simon A. Gayther, Graham G. Giles, Andrew K. Godwin, Mark S. Goldberg, David E. Goldgar, Anna González‐Neira, Mark H. Greene, Jacek Gronwald, Pascal Guénel, Lothar Häberle, Eric Hahnen, Christopher A. Haiman, Christopher R. Hake, Per Hall, Ute Hamann, Elaine F. Harkness, Bernadette A. M. Heemskerk‐Gerritsen, Peter Hillemanns ほか 176 名 - Nature Genetics 2020 被引用: 567

  7. Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents

    著者: , , , , , , , , , , , , , , , - Cancer Discovery 2012 被引用: 689

  8. TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 500

  9. Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2020 被引用: 259

  10. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu - Annals of Oncology 2017 被引用: 1,255

  11. Cancer Risks Associated With GermlinePALB2Pathogenic Variants: An International Study of 524 Families

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antoine De Pauw, Orland Dı́ez, Jill S. Dolinsky, Susan M. Domchek, Christoph Engel, D. Gareth Evans, Florentia Fostira, Judy E. Garber, Lisa Golmard, Ellen L. Goode, Stephen B. Gruber, Eric Hahnen, Christopher R. Hake, Tuomas Heikkinen, Judith Hurley, Ramūnas Janavičius, Zdeněk Kleibl, Petra Kleiblová, Irene Konstantopoulou, Anders Kvist, Holly LaDuca, Ann S. G. Lee, Fabienne Lesueur, Eamonn R. Maher, Arto Mannermaa, Siranoush Manoukian, Rachel McFarland, Wendy McKinnon, Alfons Meindl, Kelly Metcalfe, Nur Aishah Mohd Taib, Jukka S. Moilanen, Katherine L. Nathanson, Susan L. Neuhausen, Pei Sze Ng, Tú Nguyen‐Dumont, Sarah M. Nielsen, Florian Obermair, Kenneth Offit, Olufunmilayo I. Olopade, Laura Ottini, Judith Penkert, Katri Pylkäs, Paolo Radice, Susan J. Ramus, Vilius Rudaitis, Lucy Side, Rachel Silva‐Smith, Valentina Silvestri, Anne‐Bine Skytte, Thomas Slavin, Jana Soukupová, Carlo Tondini, Alison H. Trainer, Gary Unzeitig, Lydia Usha, Thomas van Overeem Hansen, James Whitworth, Marie Wood, Cheng Har Yip, Sook‐Yee Yoon, Amal Yussuf, George Zogopoulos, David E. Goldgar, John L. Hopper, Georgia Chenevix‐Trench, Paul D.P. Pharoah, Sophia George, Judith Balmañà, Claude Houdayer ほか 19 名 - Journal of Clinical Oncology 2019 被引用: 418

  12. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages

    著者: , , , , , , , , , , , , , - Nature Communications 2020 被引用: 273

  13. A human breast atlas integrating single-cell proteomics and transcriptomics

    著者: , , , , , , , , , , , , , , , , , , - Developmental Cell 2022 被引用: 163

  14. PARP inhibition in breast cancer: progress made and future hopes

    著者: , - npj Breast Cancer 2022 被引用: 148

  15. Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2017 被引用: 242

  16. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

    著者: , , , , , , , , , , , , , , - The Lancet 2010 被引用: 1,636

  17. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Monica Barile, Sara Volorio, Barbara Pasini, Riccardo Dolcetti, Anna Laura Putignano, Laura Ottini, Paolo Radice, Ute Hamann, Muhammad Usman Rashid, Frans B.L. Hogervorst, Mieke Kriege, Rob B. van der Luijt, Susan Peock, Debra Frost, D. Gareth Evans, Carole Brewer, Lisa Walker, Mark T. Rogers, Lucy Side, Catherine Houghton, JoEllen Weaver, Andrew K. Godwin, Rita K. Schmutzler, Barbara Wappenschmidt, Alfons Meindl, Karin Kast, Norbert Arnold, Dieter Niederacher, Christian Sutter, Helmut Deißler, Doroteha Gadzicki, Sabine Preisler‐Adams, Raymonda Varon-Mateeva, Ines Schönbuchner, Heidrun Gevensleben, Dominique Stoppa‐Lyonnet, Muriel Belotti, Laure Barjhoux, Claudine Isaacs, Beth N. Peshkin, Trinidad Caldés, Miguel de la Hoya, Carmen Cañadas, Tuomas Heikkinen, Päivi Heikkilä, Kristiina Aittomäki, Ignacio Blanco, Conxi Lázaro, Joan Brunet, Bjarni A. Agnarsson, Aðalgeir Arason, Rósa B. Barkardóttir, Martine Dumont, Jacques Simard, Marco Montagna, Simona Agata, Emma D’Andrea, Max Yan, Stephen B. Fox, Timothy R. Rebbeck, Wendy S. Rubinstein, Nadine Tung, Judy E. Garber, Xianshu Wang, Zachary Fredericksen, V. Shane Pankratz, Noralane M. Lindor, Csilla I. Szabo, Kenneth Offit, Rita A. Sakr ほか 33 名 - Cancer Epidemiology Biomarkers & Prevention 2012 被引用: 668

  18. Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 被引用: 521

  19. Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Song Yao, Judy E. Garber, Angela Cox, Hiltrud Brauch, Christine B. Ambrosone, Heli Nevanlinna, Drakoulis Yannoukakos, Susan L. Slager, Celine M. Vachon, Diana M. Eccles, Peter A. Fasching - Journal of Clinical Oncology 2014 被引用: 684

  20. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer

    著者: , , , , , , , , , , , - Oncotarget 2016 被引用: 621

  21. The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome

    著者: , , , , , , , , - The American Journal of Surgical Pathology 2006 被引用: 919

  22. Exemestane for Breast-Cancer Prevention in Postmenopausal Women

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 961

  23. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2018 被引用: 519

  24. Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set

    著者: , , , , , , , , , , , - JAMA Oncology 2021 被引用: 146